Maldonado, Xavier - Search Results - UAB Digital Repository of Documents

Search collections:

Sort by:	Display results:	Output format:

Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found

Articles	1 records found

$Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer$

12 p, 1.1 MB

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer / Lara, Pedro C. (Centro Oncológico Integral de Canarias. Hospital Universitario San Roque. Universidad Fernando Pessoa Canarias) ; Rodríguez-Melcón, Juan I. (Hospital Universitario de Gran Canaria Doctor Negrín. Oncología Radioterápica) ; Palacios-Eito, Amalia (Hospital Universitario "Reina Sofía" (Còrdova). Instituto Maimónides de Investigación Biomédica de Córdoba. Oncología Radioterápica) ; Lozano, Antonio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Hervás-Morón, Asunción (Hospital Ramón y Cajal. Oncología Radioterápica) ; Villafranca, Elena (Hospital Universitario de Navarra. Oncología Radioterápica) ; Gómez-Iturriaga, Alfonso (Hospital Universitario Cruces. BioCruces. Oncología Radioterápica) ; Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Maldonado, Xavier (Vall d'Hebron Institut d'Oncologia)
Background: Intermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight gain, loss of libido, and hot flashes. [...]
2022 - DOI (Digital Object Identifier)

10.3389/fonc.2022.891886
Frontiers in Oncology, Vol. 12 (July 2022) , p. 891886

Detailed record -

See also: similar author names

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.